secwatch.observer — SEC 8-K summary
======================================

Issuer:     GALECTIN THERAPEUTICS INC (GALT)
CIK:        0001133416
Form:       8-K
Filed at:   2024-09-09T23:59:59+00:00
Accession:  0001140361-24-040509
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galectin posts updated corporate presentation; no specific material changes detailed
--------------------------------------------------------------------------------

- Updated corporate presentation posted to website on September 9, 2024.
- Presentation intended for use at investor conferences and meetings.
- Filing does not disclose specific financial or pipeline updates beyond the presentation format.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133416/000114036124040509/0001140361-24-040509-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133416/000114036124040509/ef20034919_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-040509

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer